TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 1 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $22,309,000 | +1296.1% | 296,462 | +2160.5% | 0.05% | +411.1% |
Q4 2020 | $1,598,000 | +40.2% | 13,115 | +0.5% | 0.01% | +28.6% |
Q3 2020 | $1,140,000 | +35.2% | 13,052 | 0.0% | 0.01% | +16.7% |
Q2 2020 | $843,000 | +360.7% | 13,052 | +218.4% | 0.01% | +200.0% |
Q1 2020 | $183,000 | – | 4,099 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |